Safety Group Flags Cancer Evidence Against Popular Unapproved Peptide
On October 13, 2026, the Partnership for Safe Medicines reported mounting evidence linking a popular unapproved peptide to cancers. Here's what it means in the exam room.
Topic
Topic
On October 13, 2026, the Partnership for Safe Medicines reported mounting evidence linking a popular unapproved peptide to cancers. Here's what it means in the exam room.
Chatelaine published 'Inside The Wild, Semi-Regulated World Of Botox Parties,' a feature on injection services outside licensed c…
Dermatology Advisor brands aesthetic medicine "the Wild West": demand for cosmetic procedures is booming while injector training…
Proper training is now the make-or-break variable for medical aesthetics, Medical News Bulletin argues, as the field's growth out…
After five years of paper-based incident tracking, a dermatology clinic has adopted aviation-style safety reporting, betting on s…
University of Miami clinicians are building infrastructure — training, complication pathways, patient education — to reduce harm…
Only 84 of 2,777 registered Korean plastic surgery and dermatology clinics employ an anesthesiologist, yet sedation with propofol…
Tighter Philippine rules on injectables and energy-based devices now require physician oversight, reshaping clinic economics and…
The AADA and the New York State Society of Dermatology and Dermatologic Surgery issue a joint statement supporting a New York Cit…
WFMZ's Health Beat calls the social-media "Barbie Peptide" tanning trend a warning, not a cosmetic novelty — a signal dermatologi…